Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer AB
Update Il y a 4 ans
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orally, Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo, in Subjects With Mixed Dyslipidemia (Frederickson Types IIa and IIb)
The primary objective of this study is to evaluate the LDL C lowering and HDL C elevating efficacy of torcetrapib 60 mg administered in a fixed combination with atorvastatin 10 to 80 mg/day compared t...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A PHASE 2 RANDOMIZED, DOUBLE-BLINDED, DOUBLE-DUMMY, PLACEBO AND ACTIVE CONTROLLED TWO COHORT TWO-WAY CROSS-OVER, MULTI-CENTRE CLINICAL TRIAL TO EXAMINE THE PAIN RELIEF PRODUCED BY 2 WEEKS OF DAILY ORAL ADMINISTRATION OF A 5-LIPOXYGENASE (5-LO) INHIBITOR PF-04191834 ALONE AND IN COMBINATION WITH NAPROXEN IN PATIENTS WITH FLARE-ENRICHED OSTEOARTHRITIS OF THE KNEE
- To evaluate the efficacy of PF-04191834 versus placebo in relieving pain in patients with osteoarthritis of the knee. - To evaluate the efficacy of PF-04191834 plus naproxen versus naproxen in relie...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer (Netherlands)
Update Il y a 4 ans
Implementation of a smoking cessation protocol in dental practices
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Phase 3, Adolescent Large Scale Safety Study
To evaluate the safety profile of rLP2086 vaccine, as measured by adverse events (AEs), during the 6-month vaccination period and 6-month postdose 3 follow-up.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 4 ans
Étude JAVELIN HEAD AND NECK 100 : étude de phase 3 randomisée, en double aveugle, visant à comparer l’efficacité de l’avélumab en association à une chimioradiothérapie standard (cisplatine et une radiothérapie définitive) à une chimioradiothérapie standard seule comme traitement de première ligne chez des patients ayant un carcinome squameux de la tête et du cou localement avancé. [essai clos aux inclusions]
Les cancers de l’oropharynx, du pharynx et du larynx constituent le 90% des cancers de la tête et du cou et sont favorisés par le tabagisme et l’abus d’alcool. Une infection par certains types du papi...
Country
France
organs
Tête et cou
Specialty
Immunothérapie - Vaccinothérapie
,
Chimiothérapie
,
Radiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Study of Pregabalin (an Approved Drug) For the Treatment of Pain Associated with PHN, Conducted at Several Clinical Sites Where all Patients Enrolled Receive Pregabalin
The primary objective is to obtain pilot prospective data to explore whether sensory symptom cluster analysis is useful for predicting treatment response in PHN. - Phenotype PHN subjects entering stu...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer AB
Update Il y a 4 ans
26-week open-label extension study evaluating the safety and tolerability of flexible doses of oral ziprasidone in adolescent subjects with schizophrenia
To assess the safety and tolerability of oral ziprasidone (40-80 mg BID) during long-term, open-label administration in adolescent subjects with schizophrenia.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc. 235 East 42nd Street NY10017
Update Il y a 4 ans
A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF CE-224,535, AN ANTAGONIST OF THE P2X7 RECEPTOR, IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN SUBJECTS WHO ARE INADEQUATELY CONTROLLED ON METHOTREXATE
The primary objective of this study is to test the efficacy of CE-224,535 vs placebo as assessed by the American College of Rheumatology 20 (ACR 20) Response Rate at 12 weeks in RA subjects inadequate...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pfizer AB
Update Il y a 4 ans
A two part study to a) investigate the reproducibility of the vaginal photoplethysmography (VPP) technique in healthy post-menopausal volunteers and subjects suffering from Female Sexual Arousal Disorder (FSAD) and b) a randomised double blind, placebo controlled 4-way crossover study to investigate the effect of single oral doses (10, 50 and 400mg) of UK-447,841 on vaginal blood flow in post-menopausal subjects suffering from FSAD
Part A: Primary: To investigate the reproducibility of the vaginal photoplethysmography (VPP) technique in healthy post-menopausal female volunteers and post-menopausal subjects suffering from FSAD. ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 5 ans
Étude JAVELIN Bladder 100 : étude de phase 3 randomisée visant à évaluer l’efficacité de l’avélumab en association aux meilleurs soins de support par rapport aux meilleurs soins de support seuls comme traitement d’entretien chez des patients ayant un cancer urothélial avancé ou métastatique sans progression après une première ligne de chimiothérapie à base de platine.
Le carcinome transitionnel de l’urothélium est une tumeur qui peut prendre naissance dans le revêtement interne de la vessie, des uretères et de l’urètre ainsi que du bassinet du rein. Le carcinome ur...
Country
France
organs
Appareil urinaire - autres
,
Rein
,
Vessie
Specialty
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Previous
9
10
11
12
13
14
15
16
17
18
Next